Chemeca Drugs Private Limited Sustainability Profile
Chemeca Drugs Private Limited, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality generic and specialty drugs. Founded in 2005, the company has established a strong presence across various operational regions, focusing on both domestic and international markets. With a commitment to innovation, Chemeca offers a diverse range of products, including formulations for chronic diseases and advanced therapeutic solutions. Their unique approach to research and development has positioned them as a trusted name in the sector, known for their stringent quality standards and regulatory compliance. Recognised for their contributions to healthcare, Chemeca Drugs has achieved significant milestones, including partnerships with leading healthcare providers and a growing portfolio of patented formulations. Their dedication to improving patient outcomes continues to drive their success in the competitive pharmaceutical landscape.
DitchCarbon Score
How does Chemeca Drugs Private Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chemeca Drugs Private Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chemeca Drugs Private Limited's reported carbon emissions
Chemeca Drugs Private Limited, headquartered in India, currently does not report any carbon emissions data, as there are no available figures for kg CO2e. Additionally, the company has not established any specific reduction targets or climate pledges. Without emissions data or commitments, it is challenging to assess their climate impact or initiatives. As of now, Chemeca Drugs Private Limited does not inherit emissions data from any parent or related organizations, indicating that their climate strategy is independent. The absence of reported emissions and reduction initiatives suggests a need for the company to develop a comprehensive approach to carbon management and sustainability in line with industry standards.
How Carbon Intensive is Chemeca Drugs Private Limited's Industry?
How Carbon Intensive is Chemeca Drugs Private Limited's Location?
Chemeca Drugs Private Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Chemeca Drugs Private Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
